PharmiWeb.com - Global Pharma News & Resources

Company Directory

PharmiWeb's Pharma Company Directory is a comprehensive and searchable listing of organisations within the Pharma, Biotech & Life Sciences sector. Use it to find partner organisations, suppliers, or even a company to work for!

As an organisation, a basic listing is FREE, and can raise your profile in the industry, making you visible to thousands of monthly site visitors.

To add your organisation to the directory, simply register as a contributor and add your organisation's details. You can also upgrade to a premium listing for only £500/year, this offers even greater scope for added content (more photos, more links, more copy), and even more exposure.

Note that we only accept contributions relating to the Pharma industry and that it will typically take 2 working days to approve (or otherwise) your details. Once approved, you will also be able to contribute press releases and event details to our site.

Create a free account to list your company for free!

Shield is a de-risked commercial stage, pharmaceutical company focused on addressing iron deficiency in adults with or without anaemia. Our clear purpose is to develop products that help patients become people again.
Shionogi B.V. (known as “Shionogi Europe”) is the European headquarters of Shionogi & Co., Ltd, a leading global research-driven pharmaceutical company based in Osaka, Japan. Since 1878, we have been striving to supply the best possible medicines to protect the health and wellbeing of the patients we serve.
Signant Health is the evidence generation company. We are focused on leveraging software, deep therapeutic and scientific knowledge, and operational expertise to consistently generate quality evidence for clinical studies across traditional, virtual, and hybrid trial models.
Silvercloud Health is the world’s leading digital mental health company, enabling healthcare organisations to deliver clinically validated digital health/therapeutic care that improves outcomes, increases access and scale while reducing costs.
Simbec-Orion is a full-service CRO, with wide therapeutic experience and specialist expertise in clinical pharmacology, oncology and rare diseases. We provide full-service clinical development solutions for small and mid-size drug developers.
We help Pharma & Biotech companies to hire better people, more quickly, with greater confidence that they’re making the right decisions.
Established 1921 in Switzerland, Sintetica is a pharmaceutical company delivering injectable anaesthetics and analgesics to patients worldwide, through innovative science and excellence in development, production and marketing. Our sites are located in Switzerland Germany, Austria and United Kingdom.
Sitryx is a biopharmaceutical company focused on regulating cell metabolism to develop disease modifying therapeutics in immuno-oncology and immuno-inflammation.
At Smith+Nephew, we design and make technology that takes the limits off living, and we help healthcare professionals achieve the same goal. Together we improve life, while also improving performance.
An effective, compelling medical communications campaign requires each component to be carefully planned, expertly crafted and seamlessly integrated to play its part with elegance and precision.
SCT provides a dedicated, superior central laboratory service, exclusively in support of Phase I-IV clinical trials, safety testing and patient monitoring services to the Pharmaceutical, Biotechnology and Research organisations in the Asia Pacific region.
Source BioScience Limited is an international provider of integrated state of the art Laboratory Services and Products. Headquartered in the UK, with offices in UK, Europe and the USA, Source BioScience is a fully owned subsidiary of SourceBio International plc, which listed on the AIM market of the London Stock Exchange in October 2020.
A leading Australian, privately owned, full-service Contract Research Organisation, specialising in providing clinical research services for pharmaceutical, medical device and biotechnology clinical trials. With a head office in Sydney, our operations are supported by a comprehensive framework of regionally based staff throughout Australia, New Zealand and The UK.
SphingoTec develops and markets innovative in vitro diagnostic (IVD) tests for novel and proprietary blood-based protein biomarkers. These tests allow for the diagnosis, outcome prediction, and monitoring of acute medical conditions, such as septic shock, circulatory failure, acute heart failure and acute kidney injury.